About Technology Issues FAQ

Links

Official Page

Phase I, Dose-Escalation Study of BKM120, an Oral Pan-Class I PI3K Inhibitor, in Patients With Advanced Solid Tumors

Phase I, Dose-Escalation Study of BKM120, an Oral Pan-Class I PI3K Inhibitor, in Patients With Advanced Solid Tumors — Distribution of the number of citations over years.

site/software © exaly; All materials licenced under CC by-SA.